Queensland’s decision to continue the pause on puberty blockers for minors is a vital safeguarding measure, especially given the Review’s conclusion that the evidence base is limited. Young people presenting to these services often have complex needs, and some are gender non-conforming or distressed while making sense of emerging same-sex attraction - they deserve time, support, and rigorous assessment, not automatic medical pathways.
As part of a coordinated international action, LGB Alliance Australia has written to the UK High Commission in Canberra to place on the record our concerns about the UK government’s proposed puberty blocker trial for children. We raised child welfare and evidence concerns, and highlighted the safeguarding risk for same-sex attracted young people.
We urged PBAC to support PBS access for postmenopausal women while adding safeguards to stop testosterone being diverted to younger women or used for “gender-affirming” purposes.
Our submission urges the NSQHS Standards review to strengthen evidence requirements, improve safeguarding for children, and ensure paediatric gender medicine is governed by rigorous, child-centred clinical standards.
LGB Alliance Australia has urged the NHMRC to strengthen its Draft Statement on Consumer and Community Involvement in Health and Medical Research. Our submission warns that the draft risks allowing advocacy interests to overshadow scientific independence and lacks strong conflict of interest safeguards. We also raise concerns about the draft’s reliance on lived experience without recognising viewpoint diversity, and we call for clearer role definitions that keep health research grounded in evidence and scientific integrity.
Our submission to the Queensland Review shows why puberty blockers and cross-sex hormones for minors are unsafe, experimental, and lack strong evidence.
We outline the risks to same-sex attracted and gender-nonconforming young people and call for a cautious, evidence-led approach that puts safeguarding first.
Children in distress need careful assessment, not fast tracked medical pathways. They deserve a genuinely impartial NHMRC review shaped by evidence, not ideology. The panel announced this week lacks balance. Prominent clinicians who support cautious, evidence based approaches are missing.
This is Gay Conversion 2.0 and it must stop. Our full statement explains why.
The NSW Government is consulting on its proposed “LGBTIQA+” Inclusion Strategy, and it’s important that lesbian, gay and bisexual people take part. The survey has several problems. It treats the “LGBTIQA+” as a homogenous group, mixes sex with identity, and hides certain questions unless you give strongly supportive answers. If LGB people don’t respond, our needs and sex-based rights risk being overlooked.
We’ve prepared clear guidance to help you navigate the survey.
